BRIEF-Biontech And Oncoc4 Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival Versus Standard-Of-Care Chemotherapy In Previously Treated Squamous Non-Small Cell Lung Cancer Patients

Reuters · 3d ago

Please log in to view news